The information in this section is intended for visitors outside the United States.
Gilead Sciences Announces First Quarter 2014 Financial Results
Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014
2013 Annual Review